158 related articles for article (PubMed ID: 24837436)
1. Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression.
Zhang Y; Berka V; Song A; Sun K; Wang W; Zhang W; Ning C; Li C; Zhang Q; Bogdanov M; Alexander DC; Milburn MV; Ahmed MH; Lin H; Idowu M; Zhang J; Kato GJ; Abdulmalik OY; Zhang W; Dowhan W; Kellems RE; Zhang P; Jin J; Safo M; Tsai AL; Juneja HS; Xia Y
J Clin Invest; 2014 Jun; 124(6):2750-61. PubMed ID: 24837436
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine kinase 1-specific inhibitor PF543 reduces goblet cell metaplasia of bronchial epithelium in an acute asthma model.
Sudhadevi T; Ackerman SJ; Jafri A; Basa P; Ha AW; Natarajan V; Harijith A
Am J Physiol Lung Cell Mol Physiol; 2024 Mar; 326(3):L377-L392. PubMed ID: 38290992
[TBL] [Abstract][Full Text] [Related]
3. Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis.
Liu XT; Huang Y; Liu D; Jiang YC; Zhao M; Chung LH; Han XD; Zhao Y; Chen J; Coleman P; Ting KK; Tran C; Su Y; Dennis CV; Bhatnagar A; Liu K; Don AS; Vadas MA; Gorrell MD; Zhang S; Murray M; Kavurma MM; McCaughan GW; Gamble JR; Qi Y
J Transl Med; 2024 Jan; 22(1):43. PubMed ID: 38200582
[TBL] [Abstract][Full Text] [Related]
4. Photoacoustic microscopy reveals the hemodynamic basis of sphingosine 1-phosphate-induced neuroprotection against ischemic stroke.
Cao R; Li J; Kharel Y; Zhang C; Morris E; Santos WL; Lynch KR; Zuo Z; Hu S
Theranostics; 2018; 8(22):6111-6120. PubMed ID: 30613286
[No Abstract] [Full Text] [Related]
5. Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity.
Childress ES; Kharel Y; Brown AM; Bevan DR; Lynch KR; Santos WL
J Med Chem; 2017 May; 60(9):3933-3957. PubMed ID: 28406646
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone improves anemia in a murine model of sickle cell disease and is associated with increased erythrocyte bis(monoacylglycerol) phosphate.
Venugopal J; Wang J; Guo C; Eitzman DT
Sci Rep; 2022 Sep; 12(1):16437. PubMed ID: 36180774
[TBL] [Abstract][Full Text] [Related]
7. Elevated adenosine signaling via adenosine A2B receptor induces normal and sickle erythrocyte sphingosine kinase 1 activity.
Sun K; Zhang Y; Bogdanov MV; Wu H; Song A; Li J; Dowhan W; Idowu M; Juneja HS; Molina JG; Blackburn MR; Kellems RE; Xia Y
Blood; 2015 Mar; 125(10):1643-52. PubMed ID: 25587035
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia.
Sun K; Zhang Y; D'Alessandro A; Nemkov T; Song A; Wu H; Liu H; Adebiyi M; Huang A; Wen YE; Bogdanov MV; Vila A; O'Brien J; Kellems RE; Dowhan W; Subudhi AW; Jameson-Van Houten S; Julian CG; Lovering AT; Safo M; Hansen KC; Roach RC; Xia Y
Nat Commun; 2016 Jul; 7():12086. PubMed ID: 27417539
[TBL] [Abstract][Full Text] [Related]
9. Acid sphingomyelinase is activated in sickle cell erythrocytes and contributes to inflammatory microparticle generation in SCD.
Awojoodu AO; Keegan PM; Lane AR; Zhang Y; Lynch KR; Platt MO; Botchwey EA
Blood; 2014 Sep; 124(12):1941-50. PubMed ID: 25075126
[TBL] [Abstract][Full Text] [Related]
10. Beneficial Role of Erythrocyte Adenosine A2B Receptor-Mediated AMP-Activated Protein Kinase Activation in High-Altitude Hypoxia.
Liu H; Zhang Y; Wu H; D'Alessandro A; Yegutkin GG; Song A; Sun K; Li J; Cheng NY; Huang A; Edward Wen Y; Weng TT; Luo F; Nemkov T; Sun H; Kellems RE; Karmouty-Quintana H; Hansen KC; Zhao B; Subudhi AW; Jameson-Van Houten S; Julian CG; Lovering AT; Eltzschig HK; Blackburn MR; Roach RC; Xia Y
Circulation; 2016 Aug; 134(5):405-21. PubMed ID: 27482003
[TBL] [Abstract][Full Text] [Related]
11. Erythrocytes retain hypoxic adenosine response for faster acclimatization upon re-ascent.
Song A; Zhang Y; Han L; Yegutkin GG; Liu H; Sun K; D'Alessandro A; Li J; Karmouty-Quintana H; Iriyama T; Weng T; Zhao S; Wang W; Wu H; Nemkov T; Subudhi AW; Jameson-Van Houten S; Julian CG; Lovering AT; Hansen KC; Zhang H; Bogdanov M; Dowhan W; Jin J; Kellems RE; Eltzschig HK; Blackburn M; Roach RC; Xia Y
Nat Commun; 2017 Feb; 8():14108. PubMed ID: 28169986
[TBL] [Abstract][Full Text] [Related]
12. HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation.
Blaho VA; Galvani S; Engelbrecht E; Liu C; Swendeman SL; Kono M; Proia RL; Steinman L; Han MH; Hla T
Nature; 2015 Jul; 523(7560):342-6. PubMed ID: 26053123
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II.
Cingolani F; Casasampere M; Sanllehí P; Casas J; Bujons J; Fabrias G
J Lipid Res; 2014 Aug; 55(8):1711-20. PubMed ID: 24875537
[TBL] [Abstract][Full Text] [Related]
14. Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory.
Hait NC; Wise LE; Allegood JC; O'Brien M; Avni D; Reeves TM; Knapp PE; Lu J; Luo C; Miles MF; Milstien S; Lichtman AH; Spiegel S
Nat Neurosci; 2014 Jul; 17(7):971-80. PubMed ID: 24859201
[TBL] [Abstract][Full Text] [Related]
15. Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension.
MacRitchie N; Volpert G; Al Washih M; Watson DG; Futerman AH; Kennedy S; Pyne S; Pyne NJ
Cell Signal; 2016 Aug; 28(8):946-55. PubMed ID: 27063355
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening Hits.
Schnute ME; McReynolds MD; Carroll J; Chrencik J; Highkin MK; Iyanar K; Jerome G; Rains JW; Saabye M; Scholten JA; Yates M; Nagiec MM
J Med Chem; 2017 Mar; 60(6):2562-2572. PubMed ID: 28231433
[TBL] [Abstract][Full Text] [Related]
17. Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.
Proia RL; Hla T
J Clin Invest; 2015 Apr; 125(4):1379-87. PubMed ID: 25831442
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte Metabolic Reprogramming by Sphingosine 1-Phosphate in Chronic Kidney Disease and Therapies.
Xie T; Chen C; Peng Z; Brown BC; Reisz JA; Xu P; Zhou Z; Song A; Zhang Y; Bogdanov MV; Kellems RE; D'Alessandro A; Zhang W; Xia Y
Circ Res; 2020 Jul; 127(3):360-375. PubMed ID: 32284030
[TBL] [Abstract][Full Text] [Related]
19. IL-18 mediates sickle cell cardiomyopathy and ventricular arrhythmias.
Gupta A; Fei YD; Kim TY; Xie A; Batai K; Greener I; Tang H; Ciftci-Yilmaz S; Juneman E; Indik JH; Shi G; Christensen J; Gupta G; Hillery C; Kansal MM; Parikh DS; Zhou T; Yuan JX; Kanthi Y; Bronk P; Koren G; Kittles R; Duarte JD; Garcia JGN; Machado RF; Dudley SC; Choi BR; Desai AA
Blood; 2021 Mar; 137(9):1208-1218. PubMed ID: 33181835
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
